Regional Dialysis Clinics Are Quietly Exiting Medicare Advantage Networks

Regional dialysis clinics are walking away from Medicare Advantage contracts, and the decisions are not being announced with press releases or public statements. They are happening quietly, one terminated agreement at a time, and patients are often the last to know.

Why Dialysis Providers Are Drawing a Hard Line

The core tension is straightforward: dialysis is expensive, and Medicare Advantage plans have not kept reimbursement rates in line with what dialysis actually costs to deliver. For a regional clinic operating two or three locations, the math on an MA contract can turn negative fast. Staff wages, supply costs, and the clinical complexity of an end-stage renal disease patient population do not compress the way an insurer’s network strategy might assume. When a plan pays below the cost of care, staying in-network becomes a financial liability rather than a business relationship.

The exit pattern tends to follow a predictable sequence. A clinic requests a rate renegotiation. The plan offers a modest adjustment – often well below what the provider needs to break even on the patient cohort. The clinic declines, issues a notice of termination, and goes out-of-network. At that point, the patient faces a choice: travel to a different in-network facility, often farther from home, or pay significantly more out of pocket to continue care at their current clinic. For dialysis patients, who typically receive treatment three days a week for three to four hours per session, this is not a minor scheduling inconvenience. It restructures their entire week.

Regional operators are in a fundamentally different position than the two large national dialysis chains, which have enough scale to negotiate harder and absorb losses on individual contracts in exchange for broader network agreements. A standalone clinic or small regional group has no such leverage. When a plan accounts for a significant share of the patient census and that plan pays below cost, the operator is essentially choosing between a slow financial bleed or a painful but decisive exit. More are choosing the exit.

Prior authorization adds another layer of friction. Dialysis is not a service patients choose on a whim – it keeps them alive. Yet some Medicare Advantage plans still require authorization for treatments, creating administrative overhead that falls on clinic staff. When a treatment is delayed or denied and then eventually approved after an appeal, the clinic has absorbed labor costs without any corresponding payment adjustment. These accumulated costs are part of why rate negotiations fail. The reimbursement conversation cannot happen in isolation from the administrative burden conversation, and plans have generally been unwilling to move on both at once.

The Patient Impact That Gets Lost in the Contracting Dispute

End-stage renal disease patients are among the most medically vulnerable populations in the country. Missing a dialysis session carries serious clinical consequences, including dangerous fluid and electrolyte imbalances that can require emergency hospitalization. When a clinic exits an MA network, the transition window between notification and contract termination is often 90 days – enough time for an insurer to update its directory, but not always enough time for a patient to locate a new in-network facility with available treatment slots and transition their care without disruption.

Transportation is a factor that rarely enters the contracting discussion but shapes patient outcomes directly. Many dialysis patients are elderly, have significant mobility limitations, and depend on Medicaid transportation benefits or family members to get to their appointments. A clinic exit that adds 20 minutes of travel time each way, three times a week, is not trivial. For a patient in a rural or semi-rural area, the nearest alternative in-network facility may not have open slots on the schedule the patient needs. The logistics alone can force missed treatments.

Medicare Advantage plans are required to maintain adequate networks, and state insurance regulators and the Centers for Medicare and Medicaid Services technically have oversight authority when networks fall short. But enforcement is inconsistent, and the process for a patient to formally complain about network adequacy – while managing a serious chronic illness – is not designed for speed. By the time a gap is documented and reviewed, the patient has usually already found some workaround, or their health has deteriorated enough to generate a hospitalization that no one formally connects back to the access disruption.

There is a secondary financial consequence for patients that goes largely unexamined. Many people enrolled in Medicare Advantage chose their plan specifically because the premium structure or supplemental benefits fit their budget. An out-of-network dialysis provider can expose a patient to cost-sharing that far exceeds what they anticipated when they selected their coverage. Some plans provide limited out-of-network coverage at a higher cost-sharing tier; others provide none. A patient who did not anticipate needing to pay out-of-network rates for dialysis when they enrolled has no easy remedy mid-year.

The billing complexity that follows a clinic exit also deserves attention. When a provider goes out-of-network, claims processing changes, EOBs become harder to read, and patients may receive bills they do not understand and cannot immediately verify. This is a documented pressure point in other specialty care settings – regional ambulance billing companies facing similar network pressures in ground transport have seen patients caught between competing billing systems in ways that generate confusion and delayed payments. Dialysis clinic exits carry the same risk, compounded by the frequency of treatment and the number of claims generated per patient per month.

What Comes Next for the Regional Operator

Some regional dialysis operators who exit Medicare Advantage contracts report that their financial position actually stabilizes once they move to traditional Medicare reimbursement exclusively, despite the reduction in patient volume. The administrative savings – fewer prior authorization requirements, more predictable payment timelines, lower denial rates – can offset some of the revenue lost when MA patients transfer out. That calculation only works if the clinic retains enough traditional Medicare patients to sustain operations, which is not guaranteed in markets where MA penetration among Medicare-eligible residents is high.

The harder question is what happens in markets where a regional clinic is the only realistic dialysis option within a reasonable distance, and that clinic cannot sustain operations under any combination of payer contracts. Closure is a different outcome than a network exit. It removes access entirely rather than redirecting it. As MA enrollment continues to grow among Medicare beneficiaries, the economics that are currently pushing individual clinics out of networks will, in some markets, eventually push them out of business – and the patients left without a local facility will not have an in-network alternative to find.